The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Anglo-German biopharmaceutical company Trigen has recruited Eversheds lawyer Justin Penman as its new head of legal.
As Trigen’s sole in-house counsel, Penman has overall responsibility for all legal matters, including protecting Trigen’s confidential information, liaising with external counsel and the company’s patent and trade mark attorneys, and general contract negotiation and management.
The move is the latest among a series of high-profile organisations poaching from private practice to bolster their IP and legal teams (see The Lawyer, 18 September).
Penman was an assistant in Eversheds' London commercial department and advised IP matters, pharmaceutical and medical device regulation and commercial law in a life sciences.
Trigen is a biopharmaceutical company, with operations in London and Munich and a leader in cardiovascular drug discovery and development, focusing on thrombosis and vascular dysfunction.